Element Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Element Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-26,274	Closed	-$463K	–	812
2019 Q1	$463K	Buy	26,274 +11,566	+79%	+$192K	0.01%	477
2018 Q4	$255K	Sell	14,708 -155	-1%	-$2.64K	0.01%	504
2018 Q3	$221K	Buy	+14,863	New	+$230K	﹤0.01%	736

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Element Capital Management's VIVO Position: Q2 2019 in Review

Element Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 26,274 shares — an estimated $463K sold.

Element Capital Management first reported a position in VIVO in Q3 2018 and held it in 3 quarters. The position peaked at $463K in Q1 2019. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Element Capital Management reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Element Capital Management sold 26,274 Meridian Bioscience Inc shares in Q2 2019, an estimated $463K.
Element Capital Management first reported a position in Meridian Bioscience Inc in Q3 2018 and held it in 3 quarters.
Element Capital Management's Meridian Bioscience Inc position peaked at $463K in Q1 2019.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.